{
    "clinical_study": {
        "@rank": "58605", 
        "arm_group": [
            {
                "arm_group_label": "Intranasal Insulin", 
                "arm_group_type": "Experimental", 
                "description": "Intranasal Insulin"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will evaluate safety and efficacy of intranasal insulin in abstinent smokers.\n      Groups' (placebo vs. insulin) cognitive function and stress response will be compared."
        }, 
        "brief_title": "Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome", 
        "condition": "Tobacco Abstinence Syndrome", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  smokers (>10 cig/day) for the past 1 year\n\n          -  normosmic olfactory function\n\n        Exclusion Criteria:\n\n          -  previous/current use of insulin\n\n          -  current Diagnostic and Statistical Manual-IV-Revised (DSM-IV-R) Axis I disorder\n\n          -  current pregnancy (or lactation)\n\n          -  lifetime history of endocrine disease\n\n          -  excessive alcohol use (>25 standard units of alcohol/week)\n\n          -  current use of illicit drugs\n\n          -  current use of a smoking cessation aid (NRT, Chantix or Wellbutrin), or a\n             psychotropic agent\n\n          -  local infections, inflammation, structural abnormalities, or other nasal pathology\n\n          -  current use of any medications administered intranasally, including intranasal\n             steroids"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01781234", 
            "org_study_id": "UNM-246"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intranasal Insulin", 
                "intervention_name": "Intranasal Insulin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Insulin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 20, 2013", 
        "location": {
            "contact": {
                "email": "ahamidovic@salud.unm.edu", 
                "last_name": "Ajna Hamidovic, PharmD", 
                "phone": "505-272-4742"
            }, 
            "facility": {
                "address": {
                    "city": "Albuquerque", 
                    "country": "United States", 
                    "state": "New Mexico", 
                    "zip": "87131"
                }, 
                "name": "UNM College of Pharmacy"
            }, 
            "investigator": {
                "last_name": "Ajna Hamidovic, PharmD, MS", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "other_outcome": {
            "measure": "subjective measure of mood and craving", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "episodic  memory, salivary cortisol", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01781234"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of New Mexico", 
            "investigator_full_name": "Ajna Hamidovic", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "working memory, continuous attention, psychomotor speed.", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "University of New Mexico", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ajna Hamidovic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}